Kanchan Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KANCHAN HLTHCARE
KANCHAN HLTHCARE has six approved drugs.
Summary for Kanchan Hlthcare
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for Kanchan Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kanchan Hlthcare | LACOSAMIDE | lacosamide | TABLET;ORAL | 218014-003 | Apr 2, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kanchan Hlthcare | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217151-001 | Jul 25, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kanchan Hlthcare | MYAMBUTOL | ethambutol hydrochloride | TABLET;ORAL | 016320-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
